Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 128 articles:
HTML format
Text format



Single Articles


    March 2019
  1. CRIMI G, Moramarco L, Mandurino-Mirizzi A, Quaretti P, et al
    The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion strategy in a patient with embolic myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Mar 9. doi: 10.1002/ccd.28167.
    PubMed     Text format     Abstract available


  2. SETO AH, Kern MJ
    The calculus of preloading antiplatelet agents in ST-elevation myocardial infarction: Does it make a difference?
    Catheter Cardiovasc Interv. 2019;93:602-603.
    PubMed     Text format     Abstract available


    February 2019
  3. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Text format     Abstract available


  4. FU Y, Gu XS, Hao GZ, Jiang YF, et al
    Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28112.
    PubMed     Text format     Abstract available


    January 2019
  5. HUANG X, Redfors B, Chen S, Gersh BJ, et al
    Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28096.
    PubMed     Text format     Abstract available


  6. NDREPEPA G, Cassese S, Hashorva D, Kufner S, et al
    Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28098.
    PubMed     Text format     Abstract available


  7. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Text format     Abstract available


    December 2018
  8. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Text format     Abstract available


    November 2018
  9. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Text format     Abstract available


  10. GE J, Li J, Dong B, Ning X, et al
    Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
    PubMed     Text format     Abstract available


    October 2018
  11. GE Z, Baber U, Claessen BE, Farhan S, et al
    The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27860.
    PubMed     Text format     Abstract available


  12. FABRIS E, Van't Hof A, Hamm CW, Lapostolle F, et al
    Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27921.
    PubMed     Text format     Abstract available


    September 2018
  13. OGUNBAYO GO, Misumida N, Ayoub K, Hailemariam Y, et al
    Temporal trends, characteristics and outcomes of fibrinolytic therapy for ST-elevation myocardial infarction among patients 80 years or older.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27833.
    PubMed     Text format     Abstract available


  14. PEPE M, Cafaro A, Paradies V, Signore N, et al
    Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27863.
    PubMed     Text format     Abstract available


  15. WANG YS, Zhang J, Li YF, Chen BR, et al
    A pilot clinical study of adjunctive therapy with selective intracoronary hypothermia in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27864.
    PubMed     Text format     Abstract available


  16. DAVID SW, Khan ZA, Patel NC, Metzger DC, et al
    Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27905.
    PubMed     Text format     Abstract available


  17. SHETABI K, Ullah R, Patel R, Wilson T, et al
    Contemporary practice pattern of revascularization in a large tertiary care referral center in non-ST elevation myocardial infarction: A propensity-matched 10-year experience.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27839.
    PubMed     Text format     Abstract available


  18. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Text format     Abstract available


  19. KIMURA T, Nishibori Y, Miki K, Maruyama T, et al
    Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27787.
    PubMed     Text format     Abstract available


  20. IBRAHIM H, Kaltenbach LA, Hess CN, Recchia T, et al
    Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27816.
    PubMed     Text format     Abstract available


  21. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
    Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
    PubMed     Text format     Abstract available


  22. BOI A, Sanna F, Rossi A, Loi B, et al
    Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
    PubMed     Text format     Abstract available


  23. BRUGALETTA S, Cequier A, Alfonso F, Iniguez A, et al
    MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27825.
    PubMed     Text format     Abstract available


  24. KORNOWSKI R, Levi A
    Periprocedural myocardial infarction in chronic total occlusion: The challenge of precise diagnosis and prognostication.
    Catheter Cardiovasc Interv. 2018;92:486-487.
    PubMed     Text format     Abstract available


  25. CLAESSEN BE, Mehran R
    How to manage chronic total occlusions in the setting of acute myocardial infarction complicated by cardiogenic shock?
    Catheter Cardiovasc Interv. 2018;92:464-465.
    PubMed     Text format     Abstract available


    July 2018
  26. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
    Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
    PubMed     Text format     Abstract available


    May 2018
  27. GUL B, Kozuma K, Haimi I, Zhao W, et al
    Sex disparities in acute myocardial infarction care and outcomes.
    Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27622.
    PubMed     Text format     Abstract available


  28. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed     Text format    


    April 2018
  29. MCNEICE A, Nadra IJ, Robinson SD, Fretz E, et al
    The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2018 Apr 26. doi: 10.1002/ccd.27648.
    PubMed     Text format     Abstract available


    March 2018
  30. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed     Text format    


  31. GOINS AE, Rayson R, Caughey MC, Sola M, et al
    Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27625.
    PubMed     Text format     Abstract available


  32. GOLDSWEIG AM, Wang Y, Forrest JK, Cleman MW, et al
    Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27576.
    PubMed     Text format     Abstract available


  33. KHAN AA, Dangas GD
    Coronary chronic total occlusions: How to dilate the tough ones.
    Catheter Cardiovasc Interv. 2018;91:667-668.
    PubMed     Text format     Abstract available


    February 2018
  34. BRILAKIS ES, Eckman P
    The five key "ingredients" for improving outcomes in cardiogenic shock complicating acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:462-463.
    PubMed     Text format     Abstract available


  35. BUTMAN S
    KISS for in-stent restenosis.
    Catheter Cardiovasc Interv. 2018;91:434.
    PubMed     Text format     Abstract available


  36. URETSKY BF
    All stent strut malappositions are not created equal.
    Catheter Cardiovasc Interv. 2018;91:376-377.
    PubMed     Text format     Abstract available


  37. CAPRANZANO P, Capodanno D, Brugaletta S, Latib A, et al
    Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.
    Catheter Cardiovasc Interv. 2018;91:444-453.
    PubMed     Text format     Abstract available


  38. GASPARINI GL, Oreglia JA, Reimers B
    Self-apposing stent-assisted coil embolization for the treatment of coronary artery aneurysm.
    Catheter Cardiovasc Interv. 2018;91:470-474.
    PubMed     Text format     Abstract available


  39. PURI R, Otaegui I, Sabate M, Serra-Penaranda A, et al
    Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite(R) drug-eluting stent: The ANCHOR study.
    Catheter Cardiovasc Interv. 2018;91:435-443.
    PubMed     Text format     Abstract available


  40. WALDO SW, O'Donnell CI, Prouse A, Plomondon ME, et al
    Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.
    Catheter Cardiovasc Interv. 2018;91:425-433.
    PubMed     Text format     Abstract available


  41. SETHI A, Singbal Y, Rastogi U, Prasad VS, et al
    Late Incomplete stent apposition is associated with late/very late stent thrombosis: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:365-375.
    PubMed     Text format     Abstract available


  42. QIAN F, Zhong Y, Hannan EL
    Four-year comparative effectiveness of bare-metal and everolimus-eluting stents in New York.
    Catheter Cardiovasc Interv. 2018;91:417-424.
    PubMed     Text format     Abstract available


  43. ROZEMEIJER R, Stein M, Frambach P, Voskuil M, et al
    Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
    Catheter Cardiovasc Interv. 2018;91:410-416.
    PubMed     Text format     Abstract available


  44. VAN BOMMEL RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, et al
    Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
    Catheter Cardiovasc Interv. 2018;91:E21-E28.
    PubMed     Text format     Abstract available


  45. CAMPOS CM, Caixeta A, Franken M, Bartorelli AL, et al
    Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND an
    Catheter Cardiovasc Interv. 2018;91:387-395.
    PubMed     Text format     Abstract available


  46. GAO G, Feng L, Zhang D, Song C, et al
    Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  47. AFOLABI A, Mustafina I, Zhao L, Li L, et al
    Does spotty calcification attenuate the response of nonculprit plaque to statin therapy?: A serial optical coherence tomography study.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  48. ZHAO Z, Zhang D, Xu B, Wang H, et al
    Is side branch lesion length an independent predictor of acute side branch occlusion in provisional strategy? Analysis of 524 consecutive bifurcation lesions.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  49. HE Y, Zhang D, Yin D, Zhu C, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  50. XU JJ, Gao Z, Zhang Y, Gao LJ, et al
    Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  51. SONG L, Li J, Guan C, Jing Q, et al
    Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  52. SONG L, Guan C, Yan H, Qiao S, et al
    Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed     Text format     Abstract available


  53. WANG XZ, Zhang YJ, Fu GS, Jing QM, et al
    One-year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus-eluting scaffold in patients with single de novo coronary artery lesions.
    Catheter Cardiovasc Interv. 2018 Feb 2. doi: 10.1002/ccd.27491.
    PubMed     Text format     Abstract available


  54. CHATTERJEE A, Hillegass WB
    The promise of effective P2Y12 platelet receptor pretreatment: Not crushed yet.
    Catheter Cardiovasc Interv. 2018;91:251-252.
    PubMed     Text format     Abstract available


  55. BRILAKIS ES, Krestyaninov O
    Wanted: Expert operators for coronary chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:180-181.
    PubMed     Text format     Abstract available


  56. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Text format     Abstract available


  57. BUTMAN SM
    If not now, why are you waiting?
    Catheter Cardiovasc Interv. 2018;91:265-266.
    PubMed     Text format     Abstract available


  58. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Text format     Abstract available


  59. MAHMOUD AN, Saad M, Elgendy AY, Mentias A, et al
    Deferred or immediate stent implantation for primary percutaneous coronary intervention: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2018;91:260-264.
    PubMed     Text format     Abstract available


  60. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
    A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:234-241.
    PubMed     Text format     Abstract available


  61. YOON MH, Tahk SJ, Lim HS, Yang HM, et al
    Myocardial Mass Contributes to the Discrepancy Between Anatomic Stenosis Severity Assessed by Intravascular Ultrasound and Fractional Flow Reserve in Intermediate Lesions of the Coronary Artery.
    Catheter Cardiovasc Interv. 2018;91:182-191.
    PubMed     Text format     Abstract available


  62. NDREPEPA G, Colleran R, Braun S, Xhepa E, et al
    Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018;91:215-223.
    PubMed     Text format     Abstract available


  63. ARORA S, Matsushita K, Qamar A, Stacey RB, et al
    Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study.
    Catheter Cardiovasc Interv. 2018;91:253-259.
    PubMed     Text format     Abstract available


  64. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:203-212.
    PubMed     Text format     Abstract available


  65. MAEREMANS J, Spratt JC, Knaapen P, Walsh S, et al
    Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score.
    Catheter Cardiovasc Interv. 2018;91:192-202.
    PubMed     Text format     Abstract available


    January 2018
  66. LIU S, Song C, Zhao Y, Zhu C, et al
    The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
    PubMed     Text format     Abstract available


  67. DONG H, Che W, Jiang X, Peng M, et al
    Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
    Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
    PubMed     Text format     Abstract available


  68. XU N, Tang XF, Yao Y, Zhao X, et al
    Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Jan 13. doi: 10.1002/ccd.27495.
    PubMed     Text format     Abstract available


  69. VO MN, Brilakis ES, Grantham JA
    Novel use of cutting balloon to treat subintimal hematomas during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:53-56.
    PubMed     Text format     Abstract available


  70. GASPARINI GL, Oreglia JA, Garbo R
    The trap and occlude technique for retrograde wire externalization during chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2018;91:57-63.
    PubMed     Text format     Abstract available


  71. BRUGALETTA S, Gomez-Lara J, Caballero J, Ortega-Paz L, et al
    TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER-BVS trial): Rationale and study design.
    Catheter Cardiovasc Interv. 2018;91:1-6.
    PubMed     Text format     Abstract available


  72. TARANTINI G, Mojoli M, Masiero G, Cortese B, et al
    Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
    Catheter Cardiovasc Interv. 2018;91:E1-E16.
    PubMed     Text format     Abstract available


  73. CORTESE B, Rigattieri S, Aranzulla TC, Russo F, et al
    Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club.
    Catheter Cardiovasc Interv. 2018;91:97-102.
    PubMed     Text format     Abstract available


    December 2017
  74. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Text format     Abstract available


  75. BASIR MB, Schreiber T, Dixon S, Alaswad K, et al
    Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27427.
    PubMed     Text format     Abstract available


  76. GIUSTINO G, Dangas GD
    Ischemia-reperfusion injury and ischemic post-conditioning in acute myocardial infarction: Lost in translation.
    Catheter Cardiovasc Interv. 2017;90:1068-1069.
    PubMed     Text format     Abstract available


    November 2017
  77. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
    Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
    Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
    PubMed     Text format     Abstract available


  78. GOLDSTEIN JA
    Peri-procedural myocardial infarction: Plaques and patients "at-risk".
    Catheter Cardiovasc Interv. 2017;90:915-916.
    PubMed     Text format     Abstract available


  79. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
    PubMed     Text format     Abstract available


    October 2017
  80. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed     Text format    


  81. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Text format     Abstract available


    September 2017
  82. YUDI MB, Farouque O, Andrianopoulos N, Ajani AE, et al
    Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27325.
    PubMed     Text format     Abstract available


  83. WATANABE H, Morimoto T, Shiomi H, Kawaji T, et al
    Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry).
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27330.
    PubMed     Text format     Abstract available


  84. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
    Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
    PubMed     Text format     Abstract available


  85. GIUSTINO G, Dangas GD
    Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2017;90:396-397.
    PubMed     Text format     Abstract available


    August 2017
  86. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Text format     Abstract available


  87. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Text format     Abstract available


  88. AGRAWAL M, Hakeem A, Ahmed Z, Uretsky BF, et al
    Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2017;90:225-232.
    PubMed     Text format     Abstract available


    July 2017
  89. MANGELS DR, Giri J, Hirshfeld J, Wilensky RL, et al
    Robotic-assisted percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Jul 19. doi: 10.1002/ccd.27205.
    PubMed     Text format     Abstract available


  90. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Text format     Abstract available


  91. MIGLIORINI A, Valenti R, Vergara R, Grazia De Gregorio M, et al
    Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
    Catheter Cardiovasc Interv. 2017;90:72-77.
    PubMed     Text format     Abstract available


    June 2017
  92. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Text format     Abstract available


  93. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Text format     Abstract available


    May 2017
  94. BRENER MI, Bush A, Miller JM, Hasan RK, et al
    Influence of radial versus femoral access site on coronary angiography and intervention outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 May 25. doi: 10.1002/ccd.27043.
    PubMed     Text format     Abstract available


  95. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Text format     Abstract available


  96. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
    Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
    PubMed     Text format     Abstract available


  97. SETO AH, Dehghani P, Shah B, Anwaruddin S, et al
    Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.
    Catheter Cardiovasc Interv. 2017;89:1028-1034.
    PubMed     Text format     Abstract available


  98. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Text format     Abstract available


  99. WERNER GS, Glaser P, Coenen A, Moehlis H, et al
    Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates.
    Catheter Cardiovasc Interv. 2017;89:1005-1012.
    PubMed     Text format     Abstract available


  100. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Text format     Abstract available


  101. ANDRADE PB, Mattos LA, Rinaldi FS, Bienert IC, et al
    Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
    Catheter Cardiovasc Interv. 2017;89:976-982.
    PubMed     Text format     Abstract available


    April 2017
  102. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available


  103. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
    Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
    PubMed     Text format     Abstract available


    March 2017
  104. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
    Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
    PubMed     Text format     Abstract available


  105. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
    Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
    Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
    PubMed     Text format     Abstract available


  106. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available


  107. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
    The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
    PubMed     Text format     Abstract available


  108. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available


  109. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available


  110. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
    One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
    PubMed     Text format     Abstract available


  111. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
    Ischemic postconditioning during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
    PubMed     Text format     Abstract available


  112. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Text format     Abstract available


  113. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available


    February 2017
  114. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available


  115. VISVESWARAN GK, Cohen M, Seliem A, DiVita M, et al
    A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26908.
    PubMed     Text format     Abstract available


    December 2016
  116. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
    Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
    PubMed     Text format     Abstract available


    November 2016
  117. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
    Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
    PubMed     Text format     Abstract available


  118. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
    Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
    PubMed     Text format     Abstract available


  119. SHAH R, Matin K, Rogers KC, Rao SV, et al
    Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
    PubMed     Text format     Abstract available


    September 2016
  120. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
    Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
    PubMed     Text format     Abstract available


  121. SUKUL D, Seth M, Dixon SR, Zainea M, et al
    Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
    PubMed     Text format     Abstract available


    August 2016
  122. KANG SJ, Yang DH, Koo HJ, Yun SC, et al
    Intravascular ultrasound-derived morphological predictors of myocardial ischemia assessed by stress myocardial perfusion computed tomography.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26710.
    PubMed     Text format     Abstract available


  123. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Text format     Abstract available


  124. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Text format     Abstract available


  125. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Text format     Abstract available


  126. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
    Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
    PubMed     Text format     Abstract available


  127. RHEUDE TA, Xhepa E, Byrne RA
    Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26694.
    PubMed     Text format     Abstract available


    July 2016
  128. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: